A year after it was presented to the largest scientific gathering in the world, Egypt receives treatment for diabetics with one injection per day

Subscribe to receive the most important news

–
–

Last September, the activities of the 55th session of the European Association for the Study of Diabetes – the largest annual gathering in the world to discuss the new in diabetes treatments – witnessed the announcement of a new insulin, which the participating doctors described at the time as a new revolution in the world of insulin and diabetes treatments, during the activities of the conference that I attended. Al-Masry Al-Youm », and at that time, the officials of the international producing company confirmed the possibility of offering it in the Egyptian market, and that they are in negotiations with the government to take measures to quickly register the drug to start offering it in Egypt as soon as possible.

Today, nearly a year after the conference, the company producing this new type of insulin announced the approval of the Ministry of Health and Population to register the drug “Solica”, which contains two compounds of diabetes drugs, namely, basal insulin and its counterpart GLP1. This type of insulin is a new breakthrough. With the patient, controlling the rates of fasting and mycosis at the same time through only one injection per day (insulin glargine and lixinatide) instead of 4 injections throughout the day. The new drug is given through a pre-filled injection pen using “Solo Star” technology – which is from The most insulin injection technology in the world – according to the company’s statement, the new drug will be put on the market before the end of this year.

Dr. Hala Ramzy, head of the medical sector in Egypt and Sudan in the producing company, said that they are continuing their efforts and leadership in developing diabetes treatments and providing new treatment solutions to the patient, pointing out that Solica is a new solution that can help adults living with diabetes type 2 irregular. To reach a balance in the level of diabetes and achieve the goal of treatment.

Commenting on the introduction of this new drug in Egypt, Dr. Salah Shalabya, Professor of Diabetes and Endocrinology at the Faculty of Medicine, Ain Shams University, said that the new “Suliqua” treatment is in fact two types of treatments at the same time, meaning that it contains insulin glargine with GLP -1 Lexicenated, this wonderful combination is offered in one subcutaneous injection pen.

He added: “Some type II diabetics benefit from this new treatment, as it gives the doctor and the patient great flexibility in 3 points, which are: Firstly, two different treatments affect once a day and not two injections. Second: It greatly reduces the incidence of diabetes, which is the famous obstacle. Third: Usually, weight gain occurs with the use of insulin, but with this new treatment, there is no ability to gain weight.

The professor of diabetes and endocrinology confirmed that this treatment is prescribed by a doctor who specializes in treating diabetes, and for some cases of the second type, who will start insulin therapy.

Dr. Muhammad Reda Halawa, Head of the Department of Endocrinology and Diabetes at the Faculty of Medicine, Ain Shams University, said that the new insulin (Suliqua) avoids the patient repeated daily injections and suffices with one injection throughout the day to regulate the level of blood sugar.

He continued: “Studies have revealed the possibility of avoiding disease through an ideal lifestyle and exercise, and it is known that a diabetic takes treatment for longevity .. Now, according to some recent studies, it is possible to change the lifestyle and lose weight by between 10% and 15%. Lead to a return of the diabetes level to the normal rate, and that 10% of patients can dispense with treatment within a period of time following this proper regimen, ranging between 6 and 12 months, according to the study, whose results were impressive and encouraging to practice a healthy diet and sports regime.

Commenting on the spread of diabetes in Egypt in recent years, Dr. Salah El-Ghazaly Harb, professor of diabetes and endocrinology at Cairo University, and former president of the National Committee for Diabetes Control, confirmed that the problem of diabetes is that it has no symptoms, and most cases of the disease are discovered by chance, and from here it comes The importance of awareness-raising about disease and how to prevent it, pointing out that 15% of Egyptians are in the pre-diabetes stage according to current statistics, and 14% of diabetics do not know about their injury, hence the risk, and therefore the state must intervene to spread awareness and limit the causes of the injury, as it did Some countries, such as Singapore, have banned advertisements for foods that contain large calories, and urged citizens to exercise and avoid smoking, especially if we know that the percentage of people in the pre-diabetes stage in Egypt is 3 times more likely to suffer from the disease.